Cart
sales@molnova.com
Arnocoumarin
CAS No. 11037-15-3
Arnocoumarin( ——— )
Catalog No. M38278 CAS No. 11037-15-3
Arnocoumarin is a naural compound that can be isolated from X. arnottianum MAXIM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | Get Quote | Get Quote |
|
| 50MG | Get Quote | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameArnocoumarin
-
NoteResearch use only, not for human use.
-
Brief DescriptionArnocoumarin is a naural compound that can be isolated from X. arnottianum MAXIM.
-
DescriptionArnocoumarin is a naural compound that can be isolated from X. arnottianum MAXIM.
-
In Vitro———
-
In Vivo———
-
Synonyms———
-
PathwayOthers
-
TargetOther Targets
-
Recptor———
-
Research Area———
-
Indication———
Chemical Information
-
CAS Number11037-15-3
-
Formula Weight226.23
-
Molecular FormulaC14H10O3
-
Purity>98% (HPLC)
-
Solubility———
-
SMILES———
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. ISHII HISASHI, et al. Structural Establishment of Arnocoumarin and Arnottiacoumarin due to Chemical Modification of Marmesin and Rutaretin Methyl Ether. Chem Pharrn.Bull.26(8)2588--2600(1978).
molnova catalog
related products
-
Glaucine
Glaucine has antitussive antioxidative potential and antiviral activities it may be an anti-arthritic agent it can enhance LPS and zymosan-induced IL-10 production. Glaucine can inhibit the migration and invasion of human breast cancer cells by MMP-9 inhibitory activity attenuating IκBα and NF-κB activities.
-
HCV-1 e2 Protein (55...
HCV-1 e2 Protein (554 - 569)
-
TMB dihydrochloride
TMB dihydrochloride is an enzyme-linked immunosorbent assays (ELISA) and an excellent colorimetric substrate for the detection of horseradish peroxidase (HRP)-labeled probes used in staining procedures immunohistochemistry.
